Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Michael O'Riordan

April 05, 2023

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

New-Onset AF Not Uncommon After Mitral TEER

Todd Neale

September 13, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

Advertisement

Meta-analysis Teases Out What Drives Success in M-TEER

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Top Structural Heart News of 2023

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Women and Minorities Underrepresented in Heart Valve Trials

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

FDA Approves Pascal TEER Device for Degenerative MR

New-Onset AF Not Uncommon After Mitral TEER

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content